Seres Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $358.6M
Liabilities Breakdown FY2023
Total Liabilities: $403.5M
Asset Breakdown
Total Assets: $358.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $128.0M | 35.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $29.6M | 8.3% |
| Property, Plant & Equipment | $17.6M | 4.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $183.4M | 51.1% |
Liabilities Breakdown
Total Liabilities: $403.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.6M | 0.9% |
| Long-Term Debt | $110.0M | 27.3% |
| Other Liabilities | $289.8M | 71.8% |